共 20 条
[11]
Cochrane handbook for systematic reviews of intervensions.5.1.0. Higgins J,Green S. http://handbook.cochrane.org . 2011
[12]
Cochrane handbook for systematic reviews of intervensions.5.1.0. Higgins J,Green S. http://handbook.cochrane.org . 2011
[13]
Titrating rit-uxi mab to circulating Bcells to opti mizelymphocytolytic thera-py in idiopathic membranous nephropathy. Cravedi P,Ruggenenti P,Sghirlanzoni MC,et al. Clin J Am Soc Nephrol . 2007
[14]
Titrating rit-uxi mab to circulating Bcells to opti mizelymphocytolytic thera-py in idiopathic membranous nephropathy. Cravedi P,Ruggenenti P,Sghirlanzoni MC,et al. Clin J Am Soc Nephrol . 2007
[15]
Short-term effects of rituximab in children with steroid-and calcineurin-dependent nephrotic syndrome: a randomized controlled trial. Ravani P,Magnasco A,Edefonti A et al. Clin J Am SocNephrol . 2011
[16]
Short-term effects of rituximab in children with steroid-and calcineurin-dependent nephrotic syndrome: a randomized controlled trial. Ravani P,Magnasco A,Edefonti A et al. Clin J Am SocNephrol . 2011
[17]
Rituximab in children with resistant idiopathic nephroticsyndrome. Magnasco A,Ravani P,Edefonti A et al. Journal of the American Society of Nephrology . 2012
[18]
Rituximab in children with resistant idiopathic nephroticsyndrome. Magnasco A,Ravani P,Edefonti A et al. Journal of the American Society of Nephrology . 2012
[19]
The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. Wells GA,Shea B,O’’Connell D,Petersen J,Welch V,Losos M,Tugwell P. http://www.ohri.ca/programs/clinical_epidemiology/oxford.htm . 2010
[20]
The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. Wells GA,Shea B,O’’Connell D,Petersen J,Welch V,Losos M,Tugwell P. http://www.ohri.ca/programs/clinical_epidemiology/oxford.htm . 2010